尚高生命科学上涨6.7%，报7.01美元/股，总市值3.21亿美元

Group 1 - The core viewpoint of the news highlights the financial performance and stock movement of Sangao Life Sciences (SISI), which saw a 6.7% increase in stock price, reaching $7.01 per share, with a total market capitalization of $321 million as of August 11 [1] - Financial data indicates that as of March 31, 2025, Sangao Life Sciences reported total revenue of $259,000, a year-over-year decrease of 43.63%, and a net profit attributable to shareholders of -$18.77 million, reflecting a significant year-over-year decline of 712.38% [1] - The company is set to disclose its fiscal year 2024 annual report on September 29, with the actual disclosure date subject to company announcements [2] Group 2 - Sangao Life Sciences is committed to enhancing health and quality of life by providing safe, efficient, and high-quality health products and services [2] - The company has developed and manufactured 33 types of in vitro diagnostic reagents and related medical devices, and is also involved in the production and sale of health foods and dietary supplements [2]